HONG KONG, February 26, 2018 /PRNewswire/ --
Alma Lasers, a subsidiary of Sisram Medical Ltd ("Sisram" or the
"Company"; stock code: 1696.HK), the leading global innovator of
laser light-based, radiofrequency and ultrasound solutions for the
aesthetic and surgical markets and the #1 rated leading provider of
energy-based surgical and medical aesthetic solutions in
the Peoples Republic of China
announced today the launch of the Soprano ICE Platinum. It is the
first integrated solution that combines 3 wavelengths into one
compact applicator (Trio) for superior clinical outcomes.
The Soprano ICE Platinum is the only platform in the U.S that
offers simultaneous emission of three wavelengths, 755, 810, and
1064 to target different tissue depths covering the optimal
spectrum.
"FDA clearance of our innovative Trio applicator once again
solidifies Alma's position as the technology and market leader in
the global aesthetic market. Soprano is the most recognized brand
in the world and we once again have changed the paradigm in
aesthetic medicine. First the introduction of SHR and now trio
clustered diode technology. This speaks for our 'out of the box'
innovative products approach," said Mr. Lior Dayan, Sisram Medical's CEO.
With worldwide brand name recognition, the Soprano ICE has been
at the forefront of technology advancement having been cited in
numerous white papers, peer review articles and other professional
studies. The Soprano ICE leads the way as the gold standard in
virtually pain free laser hair removal technology and lesions with
its proven safety record and ability to treat all skin types
including tanned skin. By incorporating multiple laser wavelengths
and technologies, Soprano ICE allows practitioners to treat the
widest range of patients, hair types and lesions all year round,
administer treatments quickly and comfortably and achieve the best
possible clinical results.
As one of the top 5 global leaders in the aesthetics industry,
Alma Lasers continues to lead the laser hair removal market with
continued innovative product development. Laser hair removal
treatments continue to soar globally. Transparency Market Research,
a global market intelligence company, states that the hair removal
market is poised to gain a value of US $1.35
Billion by the end of 2022 globally. In the U.S., according
to the American Society for Aesthetic Plastic Surgeons (ASAPS),
over one million treatments were performed in 2016. Laser hair
removal was ranked as the number 3 leading non-surgical treatment
in the U.S.
About Sisram Medical Ltd
Sisram Medical Ltd. (1696.HK), the first Israeli company
to be listed on the Hong Kong Stock Exchange Main Board, is an
investment holding company specializing in medical technology for
healthcare. Sisram Medical is a subsidiary of Fosun Pharma,
the leading health & medical industry group in
China. Sisram Medical - Enhancing Quality of Life.
http://www.sisram-medical.com
Contact:
Sivan Raz, Marketing & PR manager,
T: +972-4-6275357 Ext. 330,
C: +972-54-2630020,
sivan.raz@almalasers.co.il